These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6126197)

  • 41. Haloperidol (but not ziprasidone) withdrawal enhances cocaine-induced locomotor activation and conditioned place preference in mice.
    Fukushiro DF; Alvarez Jdo N; Tatsu JA; de Castro JP; Chinen CC; Frussa-Filho R
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):867-72. PubMed ID: 17368685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice.
    Cook CD; Aceto MD; Coop A; Beardsley PM
    Psychopharmacology (Berl); 2002 Feb; 160(1):99-106. PubMed ID: 11862379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of chronic cocaine on behavior and cyclic AMP in cerebrospinal fluid of rhesus monkeys.
    Post RM; Smith CC; Squillace KM; Tallman JF
    Commun Psychopharmacol; 1979; 3(3):143-52. PubMed ID: 227642
    [No Abstract]   [Full Text] [Related]  

  • 45. omega-Amino-2-hydroxy-p-fluorobutyrophenones: synthesis and preliminary pharmacological evaluation.
    Cascio G; Erba R; Manghisi E; Biazzi A; Ferni G; Fregnan GB
    Farmaco Sci; 1980 Jul; 35(7):605-14. PubMed ID: 6108874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of new arylanalogs of ketamine.
    Burak K; Lipnicka U; Orszańska H; Rykowski Z; Witkiewicz K; Wrzesień J; Bogdal M; Krzywasiński L; Borkowska B
    Farmaco Sci; 1985 Apr; 40(4):285-98. PubMed ID: 4040474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacology of trazodone.
    Silverstrini B; Lisciani R
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):749-54. PubMed ID: 4201971
    [No Abstract]   [Full Text] [Related]  

  • 48. [Synthesis and the effect of new derivatives of perhydro-1,4,6-oxadiazocine on the central nervous system].
    Brzezińska E; Glinka R; Szadowska A; Kiełek MB
    Acta Pol Pharm; 1988; 45(5):400-5. PubMed ID: 2907843
    [No Abstract]   [Full Text] [Related]  

  • 49. Predictability and specificity of behavioral screening tests for neuroleptics.
    Worms P; Lloyd KG
    Pharmacol Ther B; 1979; 5(1-3):445-50. PubMed ID: 40263
    [No Abstract]   [Full Text] [Related]  

  • 50. [Dapiprazole in the treatment of drug withdrawal symptoms].
    Fogari R; Corradi L; Ferri F; Pasotti C; Tettamanti F
    Farmaco Prat; 1988 Sep; 43(9):279-89. PubMed ID: 2907317
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of prolonged administration of dapiprazole in rats].
    Sopranzi N; de Feo G; Pace S; Del Vecchio A; Bonaventura AR
    Clin Ter; 1991 Feb; 136(3):179-86. PubMed ID: 1673883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral effects of nimodipine in animals.
    Hoffmeister F; Benz U; Heise A; Krause HP; Neuser V
    Arzneimittelforschung; 1982; 32(4):347-60. PubMed ID: 7201803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacological and experimental psychological studies with 2 components of fly agaric (Amanita muscaria)].
    Theobald W; Büch O; Kunz HA; Krupp P; Stenger EG; Heimann H
    Arzneimittelforschung; 1968 Mar; 18(3):311-5. PubMed ID: 5696006
    [No Abstract]   [Full Text] [Related]  

  • 54. Synthesis and pharmacological evaluation of CNS activities of [1,2,3]triazolo[4,5-b][1,5]-, imidazolo[4,5-b][1,5]-, and pyrido[2,3-b][1,5]benzodiazepines. 10-Piperazinyl-4H-1,2,3-triazolo[4,5-b][1,5]benzodiazepines with neuroleptic activity.
    Chakrabarti JK; Hotten TM; Pullar IA; Steggles DJ
    J Med Chem; 1989 Oct; 32(10):2375-81. PubMed ID: 2571731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Caerulein and its analogues: neuropharmacological properties.
    Zetler G
    Peptides; 1985; 6 Suppl 3():33-46. PubMed ID: 3913910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dapiprazole, a selective alpha-1 adrenoceptor antagonist, inhibits diuresis but not polydipsia produced by amphetamine in rats.
    Nencini P; Valeri P; Morrone LA
    Brain Res Bull; 1990 Nov; 25(5):765-7. PubMed ID: 1981172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemical and pharmacological classification of neuroleptics.
    Janssen PA
    Mod Probl Pharmacopsychiatry; 1970; 5():33-44. PubMed ID: 5535847
    [No Abstract]   [Full Text] [Related]  

  • 58. BW 234U, (cis-9-[3-(3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agent.
    Ferris RM; Harfenist M; McKenzie GM; Cooper B; Soroko FE; Maxwell RA
    J Pharm Pharmacol; 1982 Jun; 34(6):388-90. PubMed ID: 6124624
    [No Abstract]   [Full Text] [Related]  

  • 59. [Experimental modeling of the cellular mechanisms of various psychopathological syndromes].
    Rabinovich MIa
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1986; 36(2):242-51. PubMed ID: 3521134
    [No Abstract]   [Full Text] [Related]  

  • 60. A behavioral pharmacological study of mafoprazine, a new phenylpiperazine derivative.
    Yamamura M; Nakagawa H; Kinoshita K; Ochiai T; Ishida R
    Jpn J Pharmacol; 1988 Oct; 48(2):203-12. PubMed ID: 3210446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.